0001104659-24-100328.txt : 20240916
0001104659-24-100328.hdr.sgml : 20240916
20240916205204
ACCESSION NUMBER: 0001104659-24-100328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240912
FILED AS OF DATE: 20240916
DATE AS OF CHANGE: 20240916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliveira Orlando
CENTRAL INDEX KEY: 0001699305
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42270
FILM NUMBER: 241302339
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zenas BioPharma, Inc.
CENTRAL INDEX KEY: 0001953926
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 WINTER ST, SUITE 1200
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-271-2954
MAIL ADDRESS:
STREET 1: 1000 WINTER ST, SUITE 1200
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Zenas BioPharma (Cayman) Ltd
DATE OF NAME CHANGE: 20221108
4
1
tm2424157-8_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-09-12
0
0001953926
Zenas BioPharma, Inc.
ZBIO
0001699305
Oliveira Orlando
C/O ZENAS BIOPHARMA, INC.
1000 WINTER ST., SUITE 1200
WALTHAM
MA
02451
0
1
0
0
Chief Commercial Officer
0
Stock Option (Right to Buy)
17.00
2024-09-12
4
A
0
410000
0
A
2034-09-11
Common Stock
410000
410000
D
The option vests as to 25% of the underlying shares of common stock on July 1, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service.
By: /s/ Chase Jayasekera, Attorney-in-Fact
2024-09-16